Skip to Content
  • Revenues ($M)$101,752
  • Revenue Percent Change0.9%
  • Profits ($M)$2,476
  • Profits Percent Change23.4%
  • Assets ($M)$53,243
  • Employees25,900
  • Market Value — as of March 31, 2016 ($M)$43,467
  • Previous Rank22
  • Morning Consult Brand Index
    C+

Over the past decade, Express Scripts has become the largest pharmacy benefit manager in the U.S. as the industry has consolidated. The company processes some 1.5 billion claims every year. The question now is if it can compete using its unique stand-alone business model with rivals like CVS Health that pursue a multi-pronged approach. Express Scripts has benefited from the wave of newly insured patients as a result of the Affordable Care Act and has significantly expanded its profit margins over the past five years, hitting 6.9% in 2015 compared to 5.4% in 2010. However, the company is at risk of losing its biggest customer. Express Scripts has been locked in a contract dispute with insurance giant Anthem, which accused Express Scripts of breach of contract and requested damages of as much as $13 billion. Anthem accounted for about 16% of Express Scripts’ revenue in 2015, and the likelihood of a contract renewal by 2019 is at stake.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Timothy C. Wentworth
Sector
Health Care
Industry
Health Care: Pharmacy and Other Services
HQ Location
St. Louis, MO
Websitehttp://www.express-scripts.com
Years on Fortune 500 List17
Employees25,900

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)$101,7520.9%
Profits ($M)$2,47623.4%
Assets ($M)$53,243-
Total Stockholder Equity ($M)$17,373-
Market Value — as of March 31, 2016 ($M)$43,467-

Profit Ratios

Profit as % of Revenues2.4%
Profits as % of Assets4.7%
Profits as % of Stockholder Equity14.3%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.56
EPS % Change (from 2014)34.8%
EPS % Change (5 year annual rate)10.4%
EPS % Change (10 year annual rate)18.2%

Total Return

Total Return to Investors (2015)3.2%
Total Return to Investors (5 year, annualized)10.1%
Total Return to Investors (10 year, annualized)15.4%